OPIANT PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
20 Jul 2021	Form 3: Ruth Matthew R., Chief Commercial Officer No securities owned
22 Mar 2021	Form 3: Lorianne Masuoka K., Director No securities owned
03 Jun 2020	Form 3: Gorman Brian, General Counsel Holds 13,500 shares of Common Stock
20 Sep 2019	Form 3: Mottiwala Aziz, Chief Commercial Officer Holds 13,500 shares of Common Stock
20 Sep 2019	Form 3: Thompson Rahsaan, General Counsel Holds 13,500 shares of Common Stock
11 Jul 2019	Form 3: Ellison Mark Jason Heath, UK Managing Director
31 Oct 2018	Form 3: Collard Craig A, Director No securities owned
13 Jun 2018	Form 3: Daly Richard J, Director No securities owned
12 Sep 2017	Form 3: O'Toole David D, Chief Financial Officer No securities owned
13 Feb 2017	Form 3: Skolnick Phil, Chief Scientific Officer No securities owned
10 Nov 2016	Form 3: Thomas Thomas T., Director No securities owned
27 Sep 2016	Form 3: MacDougall Ann L., Director No securities owned
26 Sep 2016	Form 3: Silver Gabrielle Alison, Director No securities owned
30 Oct 2015	Form 3: Wolf Geoffrey, Director Holds 48,800 shares of Common Stock par value $0.001
30 Oct 2015	Form 3: Crystal Roger, Director Holds 5,000 shares of Common Stock par value $0.001
06 Dec 2012	Form 3: Pollack Kevin, Director
31 May 2012	Form 3: Sinclair Michael, Director Holds 2,072,000 shares of Common
30 Jun 2009	Form 3: Belmont Partners, Llc, 10% owner and 1 other Holds 5,000,000 shares of Common Stock

Comments